Impact of early stages of CKD with and without proteinuria on cardiac remodelling in UK Biobank cohort

Back

ESC Professional Premium Access

Impact of early stages of CKD with and without proteinuria on cardiac remodelling in UK Biobank cohort

Session: The heart and the kidney

Topic: Renal Failure and Cardiovascular Disease

Speaker: Doctor H. Naderi (London, GB)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Hafiz Naderi

William Harvey Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

People with CKD in cardiovascular trials: a neglected population? A systematic review and evidence map

Speaker: Ms J. Colombijn (Utrecht, NL)

Renal insufficiency increases the risk of left ventricular remodeling

Speaker: Doctor J. Jin (Guangzhou, CN)

Biomarker-based clinical subphenotypes of cardiac surgery associated acute kidney injury and their association with in-hospital treatments and outcomes: a data-driven cluster analysis

Speaker: Doctor X. Huang (Beijing, CN)

Proportion of patients with systemic inflammation and their characteristics for groups at high cardiovascular risk in phase 3 randomized placebo-controlled trials of semaglutide (SELECT, SOUL, FLOW)

Speaker: Professor J. Deanfield (London, GB)

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic haemodialysis: a systematic review and meta-analysis of randomised controlled trials

Speaker: Ms M. Rodrigues Coutinho Clemente (Rio de Janeiro, BR)

Access the full session

The heart and the kidney

Speakers: Doctor H. Naderi, Ms J. Colombijn, Doctor J. Jin, Doctor X. Huang, Professor J. Deanfield...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Impact of early stages of CKD with and without proteinuria on cardiac remodelling in UK Biobank cohort

About the speaker

Doctor Hafiz Naderi

5 more presentations in this session

People with CKD in cardiovascular trials: a neglected population? A systematic review and evidence map

Renal insufficiency increases the risk of left ventricular remodeling

Biomarker-based clinical subphenotypes of cardiac surgery associated acute kidney injury and their association with in-hospital treatments and outcomes: a data-driven cluster analysis

Proportion of patients with systemic inflammation and their characteristics for groups at high cardiovascular risk in phase 3 randomized placebo-controlled trials of semaglutide (SELECT, SOUL, FLOW)

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic haemodialysis: a systematic review and meta-analysis of randomised controlled trials

Access the full session

The heart and the kidney

About the event

ESC Congress 2023

ESC 365 is supported by